6-morpholinomethyl-2-(4-methoxyphenyl)-1-benzopyran-4-one | 1204603-63-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: 6-morpholinomethyl-2-(4-methoxyphenyl)-1-benzopyran-4-one
• 英文别名: 2-(4-Methoxyphenyl)-6-(morpholin-4-ylmethyl)chromen-4-one
• CAS: 1204603-63-3
• 化学式: C₂₁H₂₁NO₄
• 分子量: 351.402
• InChiKey: POBHDGBUYVNUOO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  48
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  吗啉 、 6-chloromethyl-2-(4-methoxyphenyl)-1-benzopyran-4-one 反应 6.0h， 以48%的产率得到6-morpholinomethyl-2-(4-methoxyphenyl)-1-benzopyran-4-one
  参考文献：
  名称：

  Synthesis of 6-aminomethyl derivatives of benzopyran-4-one with dual biological properties: Anti-inflammatory-analgesic and antimicrobial

  摘要：

  A series of 6-aminomethyl-2-aryl-1-benzopyran-4-one derivatives (10-24) were synthesized. The compounds were tested for anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation actions. Among the tested compounds, six compounds 11, 13,16,18, 21 and 23 showed higher degree of anti-inflammatory activity (>75% activity of standard drug ibuprofen). In addition to remarkable anti-inflammatory activity, analgesic activity was found to be comparable with that of the standard drug ibuprofen. Compounds 16 and 21 showed a significant GI protection (with respect to ulcerogenesis) and a marked decrease in lipid peroxidation values whereas compounds 11 and 16 were found to possess antimicrobial activity against Staphylococcus aureus, Escherichia coli, Rhizopus oryza and Penicillum citrum with an MIC of 10 mu g/mL. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.08.001

文献信息

• Synthesis of 6-aminomethyl derivatives of benzopyran-4-one with dual biological properties: Anti-inflammatory-analgesic and antimicrobial
  作者：S.M. Hasan、M.M. Alam、Asif Husain、Suruchi Khanna、Mymoona Akhtar、M.S. Zaman

  DOI：10.1016/j.ejmech.2009.08.001

  日期：2009.12

  A series of 6-aminomethyl-2-aryl-1-benzopyran-4-one derivatives (10-24) were synthesized. The compounds were tested for anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation actions. Among the tested compounds, six compounds 11, 13,16,18, 21 and 23 showed higher degree of anti-inflammatory activity (>75% activity of standard drug ibuprofen). In addition to remarkable anti-inflammatory activity, analgesic activity was found to be comparable with that of the standard drug ibuprofen. Compounds 16 and 21 showed a significant GI protection (with respect to ulcerogenesis) and a marked decrease in lipid peroxidation values whereas compounds 11 and 16 were found to possess antimicrobial activity against Staphylococcus aureus, Escherichia coli, Rhizopus oryza and Penicillum citrum with an MIC of 10 mu g/mL. (C) 2009 Elsevier Masson SAS. All rights reserved.